MEF2C转录因子与精神分裂症遗传及表观遗传风险架构相关并在小鼠中改善认知
该研究利用精神病学基因组学联盟公开信息,发现精神分裂症风险位点周围序列中MEF2C基序富集;在34名受试者前额叶皮层神经元核小体中,MEF2C基序富集于受疾病相关H3K4超甲基化影响的顺式调控序列;小鼠前额叶投射神经元中Mef2c上调可增强工作记忆和物体识别认知表现。
要点
- 精神分裂症风险位点周围序列显示MEF2C基序富集。
- 患者前额叶皮层神经元中MEF2C基序富集于受H3K4超甲基化影响的调控序列。
- 小鼠前额叶Mef2c上调增强认知并重塑局部连接。
核心结论
- MEF2C转录因子与精神分裂症的遗传和表观遗传风险架构相关,且在小鼠中上调Mef2c可改善认知。
研究设计与样本
- 利用精神病学基因组学联盟公开信息分析风险位点序列的MEF2C基序富集。
- 对34名受试者(包括17例精神分裂症患者)前额叶皮层神经元核小体进行碱基对分辨率染色质分析。
- 在小鼠前额叶投射神经元中通过载体诱导Mef2c短期和长期上调,并进行认知行为测试。
- 采用Mef2c-Dam腺嘌呤甲基转移酶融合蛋白进行体内神经元基因组标记。
主要发现
- 顶级评分单核苷酸多态性周围序列显示MEF2C基序富集,这些位点以个体小效应贡献疾病遗传力。
- 患者前额叶皮层神经元核小体中,MEF2C基序富集于受组蛋白H3K4超甲基化影响的顺式调控序列,包括神经元特异性启动子和超级增强子。
- 小鼠前额叶投射神经元中Mef2c短期和长期上调在基线及致精神病药物挑战后均增强工作记忆和物体识别范式中的认知表现,并伴随局部连接重塑。
- Mef2c-Dam标记证实认知增强与MEF2C占据含经典和变异MEF2C基序的启动子相关。
临床怎么用
- 提示MEF2C可作为精神分裂症及相关障碍认知增强的潜在转录调控治疗靶点。
- 支持进一步探索转录调控因子在精神分裂症治疗中的潜力。
局限性
- 研究基于公开信息和有限样本(34名受试者),需进一步验证。
- 小鼠认知增强结果向人类临床转化尚不明确。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Large-scale consortia mapping the genomic risk architectures of schizophrenia provide vast amounts of molecular information, with largely unexplored therapeutic potential. We harnessed publically available information from the Psychiatric Genomics Consortium, and report myocyte enhancer factor 2C (MEF2C) motif enrichment in sequences surrounding the top scoring single-nucleotide polymorphisms within risk loci contributing by individual small effect to disease heritability. Chromatin profiling at base-pair resolution in neuronal nucleosomes extracted from prefrontal cortex of 34 subjects, including 17 cases diagnosed with schizophrenia, revealed MEF2C motif enrichment within cis-regulatory sequences, including neuron-specific promoters and superenhancers, affected by histone H3K4 hypermethylation in disease cases. Vector-induced short- and long-term Mef2c upregulation in mouse prefrontal projection neurons consistently resulted in enhanced cognitive performance in working memory and object recognition paradigms at baseline and after psychotogenic drug challenge, in conjunction with remodeling of local connectivity. Neuronal genome tagging in vivo by Mef2c-Dam adenine methyltransferase fusion protein confirmed the link between cognitive enhancement and MEF2C occupancy at promoters harboring canonical and variant MEF2C motifs. The multilayered integrative approaches presented here provide a roadmap to uncover the therapeutic potential of transcriptional regulators for schizophrenia and related disorders.
引用
- Mitchell AC, Javidfar B, Pothula V, et al. MEF2C transcription factor is associated with the genetic and epigenetic risk architecture of schizophrenia and improves cognition in mice. Mol Psychiatry. 2017. PMID: 28115742. doi:10.1038/mp.2016.254
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。